-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Pancreatic Cancer Drug Details: CX-072 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Glofitamab in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Glofitamab in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glofitamab in B-Cell Non-Hodgkin Lymphoma Drug Details: Glofitamab (Columvi) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986360 in Sarcomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986360 in Sarcomas Drug Details: BMS-986360 (CC-90001) is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nesuparib in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nesuparib in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nesuparib in Fallopian Tube Cancer Drug Details: JPI-547 (NOV-1402) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nesuparib in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nesuparib in Peritoneal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nesuparib in Peritoneal Cancer Drug Details: JPI-547 (NOV-1402) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nesuparib in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nesuparib in Epithelial Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nesuparib in Epithelial Ovarian Cancer Drug Details: JPI-547 (NOV-1402) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sucunamostat in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sucunamostat in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sucunamostat in Non-Alcoholic Steatohepatitis (NASH)Drug Details:Sucunamostat (SCO-792) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avexitide Acetate in Hyperinsulinemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avexitide Acetate in Hyperinsulinemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Avexitide Acetate in HyperinsulinemiaDrug Details:Avexitide acetate is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PBFT-02 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PBFT-02 in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PBFT-02 in Frontotemporal Dementia (FTD)Drug Details:PBFT-02 is under development for the treatment...